Formulation and Process Optimization of Cinnarizine Fast-Release Tablets - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Formulation and Process Optimization of Cinnarizine Fast-Release Tablets
The authors prepared granules containing cinnarizine using polyethylene glycol 6000 as a melting binder and lactose monohydrate as hydrophilic filler. The effects of binder concentration and size were studied.


Pharmaceutical Technology
Volume 33, Issue 8, pp. 53-59

5. M. Kidokoro et al., "Effect of Crystallization Behavior of Polyethylene Glycol 6000 on the Properties of Granule Prepared by Fluidized Hot Melt Granulation (FHMG)," Chem. Pharm. Bull. 51 (5), 487–493 (2003).

6. M.J. Hounslow, H.S. Tan, and A.D. Salman, "Kinetics of Fluidised Bed Melt Granulation V: Simultaneous Modelling of Aggregation and Breakage," Chem. Eng. Sci. 60 (14), 3847–3866 (2005).

7. K.J. Crowley et al., "Drug-Fatty Acid Salt with Wax-Like Properties Employed as Binder in Melt Granulation," Int. J. Pharm. 211, 9–17 (2000).

8. N. Passerini et al., "Characterization of Carbamazepine–Gelucire 50/13 Microparticles Prepared by a Spray Congealing Process using Ultrasounds," J. Pharm Sci. 91 (3), 699–707 (2002).

9. D. Rao et al., "Using a Novel Multicompartment Dissolution System to Predict the Effect of Gastric pH on the Oral Absorption of Weak Bases with Poor Intrinsic Solubility," J. Pharm. Sci. 94 (1), 199–208 (2005).

10. Y. Machida et al., "Preparation and Evaluation of Intragastric Buoyant Preparations," Drug Des. Del. 4, 155–161 (1989).

11. C.O. Agbada and P. York, "Dehydration of Theophylline Monohydrate Powder Effects of Particle Size and Sample Weight," Int. J. Pharm. 106, 33–40 (1994).

12. M.U. Uhumwangho and R.S. Okor, "Effect of Matrix Granulation and Wax Coating on the Dissolution Rates of Paracetamol Granules," African J. Biotech. 5 (9), 766–769 (2006).

13. S. Shamkant et al., "Application of Polyglycolized Glycerides in Protection of Amorphous Form of Etoricoxib during Compression," Chem. Pharm. Bull. 55 (10), 1448–1451 (2007).

14. A. Mansoor and F. Stepanek, "Formation of Hollow Core Granules by Fluid Bed In Situ Melt Granulation: Modelling and Experiments," Int. J. Pharm. 321, 108–116 (2006).

15. H.S. Tan, A.D. Salman, and M.J. Hounslow, "Kinetics of Fluidised Bed Melt Granulation I: The Effect of Process Variables," Chem. Eng. Sci. 61, 1585–1601 (2006).

16. A.D. Salman, H.S. Tan, and M.J. Hounslow, "Kinetics of Fluidised bed Melt Granulation IV: Selecting the Breakage Model," Powder Technol. 143, 65–83 (2004).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here